Cobimetinib Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with cobimetinib
L
- Lactinex (lactobacillus acidophilus)
- Lacto-Key-600 (lactobacillus acidophilus)
- lactobacillus acidophilus
- lactobacillus acidophilus / lactobacillus bulgaricus
- lactobacillus acidophilus / lactobacillus casei
- lactobacillus acidophilus / lactobacillus casei / lactobacillus rhamnosus
- lactobacillus acidophilus / lactobacillus rhamnosus
- lactobacillus acidophilus / methscopolamine
- lactobacillus casei / omega-3 polyunsaturated fatty acids
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- lactobacillus rhamnosus gg / omega-3 polyunsaturated fatty acids
- lamivudine / zidovudine
- Lamprene (clofazimine)
- Laniroif (aspirin / butalbital / caffeine)
- lapatinib
- larotrectinib
- lasmiditan
- Leader Heartburn Relief (cimetidine)
- ledipasvir / sofosbuvir
- lefamulin
- leflunomide
- Lemtrada (alemtuzumab)
- lenacapavir
- letermovir
- letrozole / ribociclib
- Leustatin (cladribine)
- levamlodipine
- levoketoconazole
- Levsin with Phenobarbital (hyoscyamine / phenobarbital)
- Levulan Kerastick (aminolevulinic acid topical)
- Lexiva (fosamprenavir)
- Lexxel (enalapril / felodipine)
- Liquid PedvaxHIB (haemophilus b conjugate (prp-omp) vaccine)
- Litfulo (ritlecitinib)
- LoCort (dexamethasone)
- Logilia (ulipristal)
- lomitapide
- lonafarnib
- lonapegsomatropin
- lopinavir / ritonavir
- Lorbrena (lorlatinib)
- lorlatinib
- Lotrel (amlodipine / benazepril)
- Lufyllin-EPG (dyphylline / ephedrine / guaifenesin / phenobarbital)
- Lumakras (sotorasib)
- Luminal (phenobarbital)
- Lupkynis (voclosporin)
- Luvox (fluvoxamine)
- Luvox CR (fluvoxamine)
- lyme disease vaccine
- LYMErix (lyme disease vaccine)
- Lynparza (olaparib)
- Lysodren (mitotane)
- Lytgobi (futibatinib)
More about cobimetinib
- cobimetinib consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.